Filing metadata

Accession number
0001169245-21-000044
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
May 24, 2021
Reporting period
May 20, 2021
Description
Insider transaction

Explore SEC Filings Hub